Biome Grow Stock Debt To Equity
| BIOIF Stock | USD 0.01 0 94.74% |
Biome Grow fundamentals help investors to digest information that contributes to Biome Grow's financial success or failures. It also enables traders to predict the movement of Biome Pink Sheet. The fundamental analysis module provides a way to measure Biome Grow's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biome Grow pink sheet.
Biome |
Biome Grow Company Debt To Equity Analysis
Biome Grow's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Biome Grow Debt To Equity | 1.45 % |
Most of Biome Grow's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biome Grow is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Biome Grow has a Debt To Equity of 1.452%. This is 97.29% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The debt to equity for all United States stocks is 97.02% higher than that of the company.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Biome Fundamentals
| Return On Equity | -4.37 | |||
| Return On Asset | -0.0844 | |||
| Current Valuation | 2.98 M | |||
| Shares Outstanding | 112.42 M | |||
| Shares Owned By Insiders | 47.31 % | |||
| Price To Earning | 0.48 X | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 2.00 X | |||
| Gross Profit | 1.13 M | |||
| EBITDA | 313.61 K | |||
| Net Income | (139.93 K) | |||
| Cash And Equivalents | 2.1 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 3.51 M | |||
| Debt To Equity | 1.45 % | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (1.84 M) | |||
| Earnings Per Share | (0.15) X | |||
| Beta | 0.41 | |||
| Market Capitalization | 1.3 M | |||
| Total Asset | 11.07 M | |||
| Net Asset | 11.07 M |
About Biome Grow Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biome Grow's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biome Grow using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biome Grow based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Biome Pink Sheet
Biome Grow financial ratios help investors to determine whether Biome Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biome with respect to the benefits of owning Biome Grow security.